Cancers form when toxins damage or mutate a cell’s DNA and cause it to grow out of control. A tumor can remain local, or the cancer can spread, and even move from one organ to another.
Most people are familiar with cigarette smoking as a cause of lung cancer. Lung cancer kills more Americans than any kind of cancer, and most (but not all) lung cancer victims are smokers. It is a particularly brutal form of cancer.
However, smoking can cause many other kinds of cancer too, because cancers can form not just in areas that have contact with the smoke, but also from smoke byproducts in the bloodstream and organs. According to the Centers for Disease Control and Prevention (CDC), smoking can cause cancer almost anywhere in the body.
Some of the cancers that can be caused by smoking are:
- Blood (leukemia)
- Colon and rectum
- Esophagus and trachea
- Kidney and renal pelvis
- Mouth and throat
Nicotine itself — either in cigarettes or e-cigs, or other nicotine products — has not been shown to cause cancer. Long-term studies of nicotine replacement therapy (NRT) and Swedish snus users show no provable link between nicotine and cancer.
The 2016 Royal College of Physicians (RCP) report “Nicotine Without Smoke” says that “robust evidence on the safety of long-term nicotine use in humans from the 5-year Lung Health Study, in which participants were actively encouraged to use NRT for several months and many continued to consume NRT for a much longer period, demonstrates no association between sustained NRT use and the occurrence of cancer (lung, gastrointestinal or any cancer) or cardiovascular disease.”
Cancers from smoking are caused by the combustion of tobacco. The smoke forms a sticky chemical slurry called tar, and the tar coats delicate parts of the lungs. Over the course of years, the damage created by tar in the lungs can lead to tumor growth. According to the National Cancer Institute (NCI), most of the cancer-causing substances in cigarette smoke are in the tar. Tar also causes damage that can lead to lung diseases like emphysema and bronchitis.
E-cigarettes don’t produce tar, because they don’t burn (or even contain) tobacco or other plant material. There are known carcinogens in vapor, but they’re in tiny concentrations that are unlikely to pose any risk to vapers. Most studies that have raised alarms about cancer risk from vaping have used poor methods, including using smoking machines to take too-frequent or too-long drags, or vaping at unrealistic high temperatures on dry wicks. Those things wouldn’t happen to actual vapers, because the result — known as dry hits or dry puffs — is unbearable to breathe.
“In normal conditions of use, toxin levels in inhaled e-cigarette vapour are probably well below prescribed threshold limit values for occupational exposure, in which case significant long-term harm is unlikely,” says the RCP report. “Some harm from sustained exposure to low levels of toxins over many years may yet emerge, but the magnitude of these risks relative to those of sustained tobacco smoking is likely to be small.”
A recent study at the University of St. Andrews in Scotland found that the cancer danger of vaping is almost as low as for nicotine replacement therapies like patches and gum — less than one percent. “This study should put to rest any doubt within the tobacco control movement about whether vaping greatly reduces health risk compared to smoking,” wrote Boston University’s Dr. Michael Siegel.
1. US Food and Drug Administration. E-Cigarettes: Questions and Answers. 2010http://www.fda.gov/forconsumers/consumerupdates/ucm225210.htm.
2. Hitchman SC, McNeill A, Brose LS. Electronic Cigarettes: Time for an Accurate and Evidence-Based Debate. Addiction. 2014;109:867–868.http://dx.doi.org/10.1111/add.12550. [PubMed]
3. Buchhalter AR, et al. Tobacco Abstinence Symptom Suppression: The Role Played by the Smoking-Related Stimuli That Are Delivered by Denicotinized Cigarettes. Addiction. 2005;100:550–559.http://dx.doi.org/10.1111/j.1360-0443.2005.01030.x. [PubMed]
4. Bullen C, et al. Effect of an Electronic Nicotine Delivery Device (E Cigarette) on Desire to Smoke and Withdrawal, User Preferences and Nicotine Delivery: Randomised Cross-Over Trial. Tobacco Control. 2010;19:98–103.http://dx.doi.org/10.1136/tc.2009.031567. [PubMed]
5. Cahn Z, Siegel M. Electronic Cigarettes as a Harm Reduction Strategy for Tobacco Control: A Step Forward or a Repeat of Past Mistakes? Journal of Public Health Policy. 2011;32:16–31.http://dx.doi.org/10.1057/jphp.2010.41. [PubMed]
6. Polosa R, et al. Effect of an Electronic Nicotine Delivery Device (E-Cigarette) on Smoking Reduction and Cessation: A Prospective 6-Month Pilot Study. BMC Public Health. 2011;11:786.http://dx.doi.org/10.1186/1471-2458-11-786. [PMC free article][PubMed]
7. Siegel MB, Tanwar KL, Wood KS. Electronic Cigarettes as a Smoking-Cessation: Tool Results from an Online Survey. American Journal of Preventive Medicine. 2011;40:472–475.http://dx.doi.org/10.1016/j.amepre.2010.12.006. [PubMed]
8. Etter JF, Bullen C. A Longitudinal Study of Electronic Cigarette Users. Addictive Behaviors. 2014;39:491–494.http://dx.doi.org/10.1016/j.addbeh.2013.10.028. [PubMed]
9. Bullen C, et al. Electronic Cigarettes for Smoking Cessation: A Randomised Controlled Trial. Lancet. 2013;382:1629–1637.http://dx.doi.org/10.1016/S0140-6736(13)61842-5. [PubMed]
10. Caponnetto P, et al. Efficiency and Safety of an Electronic Cigarette (Eclat) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study. PLoS One. 2013;8:e66317.http://dx.doi.org/10.1371/journal.pone.0066317. [PMC free article][PubMed]
11. Zhu SH, Gamst A, Lee M, Cummins S, Lu Y, Zoref L. The Use and Perception of Electronic Cigarettes and Snus among the US Population. PLoS One. 2013;8:e79332.http://dx.doi.org/10.1371/journal.pone.0079332. [PMC free article][PubMed]
12. Etter JF, Bullen C. Electronic Cigarette: Users Profile, Utilization, Satisfaction and Perceived Efficacy. Addiction. 2011;106:2017–2028.http://dx.doi.org/10.1111/j.1360-0443.2011.03505.x. [PubMed]
13. Kralikova E, Novak J, West O, Kmetova A, Hajek P. Do E-Cigarettes Have the Potential to Compete with Conventional Cigarettes? A Survey of Conventional Cigarette Smokers’ Experiences with E-Cigarettes. Chest. 2013;144:1609–1614.http://dx.doi.org/10.1378/chest.12-2842. [PubMed]
14. Breland AB, Spindle TBS, Weaver M, Eissenberg T. Science and Electronic Cigarettes: Current Data, Future Needs. Journal of Addiction Medicine. 2014;8:223–233.http://dx.doi.org/10.1097/ADM.0000000000000049. [PMC free article][PubMed]
15. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System, 2011. DeKalb County: CDC; 2012.
16. Brown RA, Burgess ES, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and Validity of a Smoking Timeline Follow-Back Interview. Psychology of Addictive Behaviors. 1998;12:101–112.http://dx.doi.org/10.1037/0893-164X.12.2.101.
17. Biener L, Abrams DB. The Contemplation Ladder: Validation of a Measure of Readiness to Consider Smoking Cessation. Health Psychology. 1991;10:360–365.http://dx.doi.org/10.1037/0278-622.214.171.1240. [PubMed]
18. Fava JL, Velicer WF, Prochaska JO. Applying the Transtheoretical Model to a Representative Sample of Smokers. Addictive Behaviors. 1995;20:189–203.http://dx.doi.org/10.1016/0306-4603(94)00062-X. [PubMed]
19. Berg CJ, et al. Use of and Interest in Smoking Cessation Strategies among Daily and Nondaily College Student Smokers. Journal of American College Health. 2012;60:194–202.http://dx.doi.org/10.1080/07448481.2011.586388. [PMC free article][PubMed]
20. Jacob P, III, Yu L, Duan M, Ramos L, Yturralde O, Benowitz NL. Determination of the Nicotine Metabolites Cotinine and Trans-3’-Hydroxycotinine in Biologic Fluids of Smokers and Non-Smokers Using Liquid Chromatography-Tandem Mass Spectrometry: Biomarkers for Tobacco Smoke Exposure and for Phenotyping Cytochrome P450 2A6 Activity. Journal of Chromatography B. 2011;879:267–276.http://dx.doi.org/10.1016/j.jchromb.2010.12.012. [PMC free article][PubMed]
21. Heavner K, Dunworth J, Bergen P, Bergen P, Phillips CV. Electronic Cigarettes (E-Cigarettes) as Potential Tobacco Harm Reduction Products: Results of an Online Survey of E-Cigarette Users. 2009http://www.tobaccoharmreduction.org/wpapers/011v1.pdf.
22. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2009: Surveys of Adult Tobacco Use in WHO Member States. 2008http://www.who.int/tobacco/mpower/mpower_report_prevalence_data_2008.pdf.
23. Palazzolo DL. Electronic Cigarettes and Vaping: A New Challenge in Clinical Medicine and Public Health. A Literature Review. Front Public Health. 2013;1:56.http://dx.doi.org/10.3389/fpubh.2013.00056. [PMC free article][PubMed]
24. Goniewicz ML, et al. Nicotine Levels in Electronic Cigarettes. Nicotine & Tobacco Research. 2013;15:158–166.http://dx.doi.org/10.1093/ntr/nts103. [PubMed]
25. Dawkins L, Corcoran O. Acute Electronic Cigarette Use: Nicotine Delivery and Subjective Effects in Regular Users. Psychopharmacology. 2014;231:401–407.http://dx.doi.org/10.1007/s00213-013-3249-8. [PubMed]
26. Etter JF. Levels of Saliva Cotinine in Electronic Cigarette Users. Addiction. 2014;109:825–829.http://dx.doi.org/10.1111/add.12475. [PubMed]
27. Etter JF, Bullen C. Saliva Cotinine Levels in Users of Electronic Cigarettes. European Respiratory Journal. 2011;38:1219–1220.http://dx.doi.org/10.1183/09031936.00066011. [PubMed]
28. Goniewicz ML, Knysak J, Gawron M, Kosmider L. Levels of Selected Carcinogens and Toxicants in Vapour from Electronic Cigarettes. Tobacco Control. 2014;23:133–139.http://dx.doi.org/10.1136/tobaccocontrol-2012-050859. [PMC free article][PubMed]
29. Barbeau AM, Burda J, Siegel M. Perceived Efficacy of E-Cigarettes versus Nicotine Replacement Therapy among Successful E-Cigarette Users: A Qualitative Approach. Addiction Science & Clinical Practice. 2013;8:5.http://dx.doi.org/10.1186/1940-0640-8-5. [PMC free article][PubMed]
30. Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, Sobczak A. Secondhand Exposure to Vapors from Electronic Cigarettes. Nicotine & Tobacco Research. 2013 Published Online. [PMC free article][PubMed]
31. Schober W, Szendreia K, Matzena W, Osiander-Fuchsb H, Heitman D. Use of Electronic Cigarettes (E-Cigarettes) Impairs Indoor Air Quality and Increases FeNO Levels of E-Cigarette Consumers. International Journal of Hygiene and Environmental Health. 2013;217:628–637.[PubMed]